(NBC) – Novavax is the latest company to receive money from the U.S. government for testing and manufacturing a potential coronavirus vaccine.
Tuesday’s $1.6 billion award is the largest yet from “Operation Warp Speed.”
The money will be for completing late-stage clinical development, including a Phase 3 clinical trial that will involve up to 30,000 people.
It will also establish large-scale manufacturing of a vaccine candidate with the goal of delivering 100 million doses by early next year.
A Phase 1 clinical trial involving 130 people began in May and those results are expected at the end of the month.